Search
Breakthrough Enables Prediction of Relapse in Common Childhood Cancer
- OPACC
- Dec 8, 2020
- 1 min read
New research has allowed experts to identify the time, nature, and outcome of pediatric medulloblastoma relapse, allowing physicians to tailor treatments for each individual patient and improve prognosis.
Recent Posts
See AllQuality of life improvements can be made if clinicians better understand auditory attention decay after cancer treatment in pediatric...
A team of experts, issuing a statement on behalf of the American Heart Association, have detailed cardiometabolic considerations for...
While the overall prevalence of comorbidities at diagnosis in pediatric patients with acute lymphoblastic leukemia (ALL) and...
Comments